New or existing modified drug Stability Testing Program's regulations/requirements stipulated by the FDA, 21 CFR or other regulations may sometimes creating an overwhelming situation based on the type of product that is being manufactured. Hence, some manufacturers of new drug products have made inadvertent mistakes in the design of their new drug stability testing program. Such mistakes may ultimately delay the new, existing or modified product IND or NDA application process due to the data that was presented to the FDA (i.e. Relevant aspects of the stability testing program requirement may have been omitted by the drug manufacturers). It is better to understand, follow and apply the full requirements of a new product stability testing requirement from the onset or to correct an existing stability testing program so as to avoid future pitfalls and delayed IND or NDA submission process by the FDA. Having produced a new or existing product, knowing the appropriate way to design and perform the stability testing of the new product which is a prerequisite for setting the product's expiration date and possible extension of the expiration date is critical. Some drug product manufacturers have made mistakes in the past whereby a new product that was manufactured appropriately did not have a good stability testing plan or program hence it delayed the product's ability to have an approved IND or NDA submission. A mistake of this sort has also been made by drug manufactures that resulted in a 483 or Warning letter by the FDA. Knowing how to approach the design of a new product stability program at the onset of the new product design or during an existing product testing is important and will save a company time and cost in moving the product to the next phase.

This Virtual Seminar will provide a great resource to Pharmaceutical, Biotechnology, Diagnostics, Cell Therapy, Drugs, Biologics, OTC, Radio-pharmaceutical, Pharmacies and Medical Device Industries in understanding the effective way to establish a new or modified product stability testing program. This program is an important part of a product's regulatory filing requirements as well as the determination of the shelf life or expiration date of the product. This is an important part of every business final bottom line or indirectly relationship to their supply and warehouse chain (how long the product can be stored before it can be discarded). Understanding how to design and implement an effective stability testing program following the regulatory guidelines will allow the product to be manufactured, tested, released, adequately stored and effectively tested for stability and ultimately used through its actual end point based on the product's potency. This will eliminate potential loss of product and business income by manufacturers of product (i.e. when a potent product is inadvertently discarded due to a poorly designed stability testing program) which ends up impacting the products' regulatory filing status or a product's Regulatory Filing/Application. The focus of this seminar will create a detailed process that will guide the attendees in the right direction in the planning of a new or existing product's stability testing plan, program, protocol, handing and utilizing the data, setting the shelf life as well as the applicable regulatory requirements.

Learning Objectives:

This Virtual Seminar will help the attendee gain a better understanding of the requirements of the FDA’s Drug Stability Guidelines that is stipulated for new, existing and modified drug products that have an existing or new IND or NDA submission.

In-Person Seminar going Virtual with increased learner satisfaction.

Yes, attend this seminar from anywhere. We are making it real and more interactive – Here's a sneak peek:

Our enhanced delivery process and technology provides you an immersive experience and will allow you to access:

  • The real-time and live presentation as in in-person events
  • Private chat for company-specific conversation – the same as you would get in an in-person seminar
  • Opportunities to connect with your peers to share knowledge at a different time and have group discussions
  • Live workshop activities
  • Live Q&A during the event and offline Q&A assistance after the event
  • As usual more content, activities and case studies and now adding homework for a comprehensive understanding
  • Certification

This Virtual Seminar will also benefit people within the Pharmaceutical, Biotechnology or Medical Device industries that are currently have a stability testing program but do not know how to maximize the use of their data for extending their product’s expiration dating.

This Virtual Seminar will provide the detailed requirements applicable to the FDA’s and 21CFR 514.1(b)(5)(x) expectations which states that “an applicant should submit data from stability studies that have been completed as well as information about studies that are underway to substantiate the request for a specific expiration date and provide information on the stability of the drug products” FDA’s Guidance for Industry. For this reason, it is important to have clarity and understanding of how to apply this regulation prior to the initiation of a new product stability testing program which includes the protocol design, testing, storage, data management, trending and expiration dating extrapolations and expectations for products in a new or existing IND or NDA application process.

Who will Benefit:

The Virtual Seminar will benefit people within the pharmaceutical, biotechnology or medical device industries that currently have a stability testing program but are not savvy about maximizing the use of their data for extending their product’s expiration dating. The employees who will benefit most include:

  • Quality Control Analyst and Management
  • Senior Management
  • Manufacturing Associates and Management
  • Shipping and Distribution Personnel
  • Stability Testing Department Personnel and Management
  • Regulatory Affairs
  • Quality Assurance Analyst and Management
  • Process Design Personnel and Management
  • Drug Packaging Personnel and Management
Register by phone or need assistance? Call +1-888-717-2436 Register Now Download Brochure
Day 01(9:00 AM to 4:00 PM EST)
  • Session 1: 9:00 am – 10:15 am
    • Topic: General Stability Considerations Applicable to a Product’s Stability (I.e. Potency), Storage Conditions, Sampling Plan and Sample Handling
    • Knowledge Base: Attendees will gain an understanding in the following key areas:
    • Introduction of a Stability Testing Plan and Program.
      • Regulatory guidance associated with the requirements of a product’s stability testing program.
      • Delineating the program requirement specific to a type of product.
      • Applicable Regulation and Requirements.
      • Purpose of a Stability testing Program
    • General Stability Considerations applicable to a New product (I.e. Potency)
      • New product stability indicator tests
      • Rationale for choosing the test and impact to the product’s shelf life.
    • Storage Conditions
      • Shelf Life Duration of Studies and Expiration Dates
      • Container Closure Requirements
  • Session 2: 10:15 am - 11:00 am
    • Sample Size
      • Sampling Plan
      • Handling and Analysis of Samples
    • Stability Schedule (Suggested Schedules for Conducting Stability Studies)
      • Pre-approval and Post Approval Studies
      • Stability Tests
      • Reformulated Products
      • Accelerated Temperature Studies
      • Test Schedule Information
        • Suggested Time Points and Expiration dates based on testing time points
        • Solid Dosage Forms Suggested Test Schedule
        • Liquid and Semi-solid Types Products Suggested Test Schedule
        • Reconstituted Products Suggested Test Schedule
  • 11:00 am – 11:15 am (Break)
  • Session 3: 11:15 am - 12: 00 pm
    • The relationship between choosing the right product storage temperature and impact to its shelf life.
      • Temperatures of Studies based on the product type
      • Room Temperature Studies
      • Elevated Temperature
      • Refrigeration
      • Freezing Temperature
      • Special Humidity Considerations
    • Container Closure Requirements.
    • Storage Temperature for various types of products.
    • Performing an effective sampling plan and utilizing the appropriate sample size for a stability testing program.
    • Performing a compliant sample analysis, handling and effecting the appropriate test specification for the product type.
  • 12:00 pm - 1:00 pm (Lunch Break)
  • Session 4: 1.00 pm - 2: 00 pm
    • Topic: Designing and Conducting Effective Stability Testing Program Using the Suggested Schedules for Various Product Types
    • Knowledge Base: Attendees will gain an understanding in the following key areas:
      • How to Conduct a Pre-approval and Post Approval Stability Testing Studies
      • Performing Various Types of Stability Tests such as Reformulated Products, Accelerated Temperature Studies and others.
      • Understanding the different Types of Stability Test Schedules Provided by Regulations Based on the following Product Types and Information:
  • Session 5: 2.00 pm - 3: 00 pm
    • Suggested Time Points and Expiration dates based on testing time points
    • Solid Dosage Forms Suggested Test Schedule
    • Liquid and Semi-solid Types Products Suggested Test Schedule
    • Reconstituted Products Suggested Test Schedule
    • Performing Different Temperatures of Studies based on the product type such as Room Temperature Studies, Elevated Temperature, Refrigeration, Freezing Temperature and Special Humidity Considerations
  • 3.00 pm - 3:15 pm (Break)
  • 3.15 pm - 4:00 pm (Review of Case Studies)
    • Review of Case Studies: Issues Encountered by Drug Product Manufacturers Based on a Poorly Designed Stability Testing Program
      1. Case Study #1 and Suggested Resolution
Day 02(9:00 AM to 4:00 PM EST)
  • Session 1: 9:00 am – 10:15 am
    • Topic: Stability Testing Protocol Design, Data Management and Trending. Comparative Analysis of Using a Manual versus Automated Data Management
    • Knowledge Base: The Attendees will gain an understanding in the following key areas:
      • How to Design an effective Stability Testing Program, Protocol and a Report for a New and Existing Product.
      • How to Effectively Handle, Manage Data, Utilize and Perform the Trending of Stability Testing Results and Data.
  • Session 2: 10:15 am - 11: 00 am
    • Topic: Analytical Testing Considerations, Review of Case Studies
    • Knowledge Base: Attendees will gain an understanding in the following key areas:
      • How to perform Quality Control Testing, Setting Test Specification and Assay Release Process in a Stability Testing Program.
      • Detailed Reasons why the Choice of a Quality Control Test Method, Specific Assays and Tests Specifications are Critical to the Success of a Product’s Stability Testing Program and Shelf Life Determination.
      • Choice of methods with meaningful data or stability indicator
      • Analytical Assay Test Method Attributes
  • 11:00 am – 11:15 am (Break)
  • Session 3: 11:15 am - 12: 00 pm
    • Using the Laboratory Information Management Systems (LIMS) in a Stability Study Program
      • Data Documentation, Entry and Management (Types of Documentation Methods)
      • The Criticality of the Choice of a Stability Test Data Management System used for Data Management.
      • Considerations when choosing a Stability Test Data Management System (Manual versus Automated Data Management)
        • Advantages and Disadvantages of each type of system
      • Types of Stability Test Data Management Software (LIMS) for Stability Test Data Management
  • 12:00 pm - 1:00 pm (Lunch Break)
  • Session 4: 1:00 pm - 2: 00 pm
    • Understanding the LIMS Stability Module Program and Statistical Analysis Tools
      • Understanding the various modules under the Stability Data Management Software in LIMS.
    • Best practices when selecting Stability test data (LIMS) Vendor
    • The various parts of the Stability test data management software
    • Common mistakes made during the purchase of some Stability data management software.
    • Choosing the best LIMS software programs used for stability test data management.
  • Session 5: 2:00 pm - 3:00 pm
    • Using Stability Testing Data to Generate the Product’s Expiration Dating or Shelf Life.
    • How to Perform the Extrapolation of a Product Shelf Life Using Data from an Ongoing Stability Testing Program
      • Great for products in clinical studies.
    • Understand the different ways of performing statistical analysis of the stability test result data (manual versus automated software).
  • 3:00 pm - 3:15 pm (Break)
  • 3:15 pm - 4:00 pm (Review of Case Studies)
    • Review of Case Studies: Issues Encountered by Drug Product Manufacturers Based on a Poorly Designed Stability Testing Program
      1. Case Study #2 and Suggested Resolution
      2. Case Study #3 and Suggested Resolution
Register by phone or need assistance? Call +1-888-717-2436 Register Now Download Brochure
Charity Ogunsanya

Charity Ogunsanya
CEO and Founder, Pharmabiodevice Consulting LLC

Charity Ogunsanya has over 30 years of extensive experience within the Pharmaceutical, Biotechnology, Biologics, Cell-Therapy, Diagnostics, Research and Development, Radio-pharmaceutical, Contract Manufacturing Organization (CMO) and Medical Device companies.

Throughout her corporate career within these diverse industries, she held various high visibility and business critical roles within the Quality and Compliance division in major Fortune 100 companies both as a Subject Matter Expert (SME), Site Manager, Multi-site Manager and Director Levels receptively. She has been a sought after expert and have been consistently hired after several competitive efforts by major fortune 100 companies to assume key roles specifically related to remediation and difficult Quality and Compliance related deficiencies associated with FDA’s Consent Decree, FDA’s Warning Letters and difficult regulatory bodies inspectional findings which is always achieved with a successful outcome. She has also been a sought after expert by various companies requesting her expertise as a known industry expert to specifically assume roles in order to perform a total overhaul, restructure, compliance remediation, re-organization, start-up processes related to Quality Systems improvements and/or enhancements. In all cases, her remediation work resulted in several successful National and International regulatory bodies’ inspections, re-inspection and new product approvals.

Her technical expertise are not limited to the interpretation, administration and set up of Quality Assurance, Quality/Compliance, Quality Engineering, Aseptic Processing, Contamination Control, Quality Control, Microbiology, Sterility Assurance, Stability, Vaccine Development, New Product Design, Product Release Testing and Medical Device Sterilization (Ethylene Oxide (EtO), Gamma, Radiation, VHP sterilization) systems and operations for compliance to various regulations.

Ms. Ogunsanya is vast in the requirements and regulations guiding new and existing products from planning through design, proof of concept, research and development, technology transfer, pre-clinical, clinical, commercial manufacturing, supply chain, regulatory filings, pre-approval inspections, licensure, government affairs, commercialization and post-approval inspections. Her expertise has been sought after by several Fortune 100 Pharmaceutical, Biotechnology, Biologics and Medical Device companies as a Quality and Compliance SME during critical national and international regulatory bodies’ routine and new product approval inspections.

She is the CEO of Pharmabiodevice Consulting LLC (www.pharmabiodeviceconsultant.com) targeted towards Quality and Compliance related remediation, enhancements and consultant services for various companies within the industry. She is a well sought after high level consultant for several international professional expert networks such as Gerson Lehrman Group, Zintro Expert Network and Intota Expert Network. She is a member of the Parenteral Drug Association (PDA), American Society of Microbiologists (ASM), and other Scientific Forums and Industry Expert Network.

Register by phone or need assistance? Call +1-888-717-2436 Register Now Download Brochure

Register Now

Online using Credit card

$1,299.00

(One Dial-in One Attendee)

(After registration, we will video stream the training on your convenient dates)
Last Recorded Date: June 14 & 15, 2021

$6,999.00

Group-Max. 10 Attendees

(After registration, we will video stream the training on your convenient dates)
Last Recorded Date: June 14 & 15, 2021



Other Registration Option

By order form / PO#

Payment Mode

By Check -
Pay your check to (payee name) “MetricStream Inc” our parent company and Mail the check to:

ComplianceOnline (MetricStream, Inc),
6201 America Center Drive Suite 240
San Jose, CA 95002
USA

By Wire -

Register / Pay by Wire Transfer

Please contact us at +1-888-717-2436 to get details of wire transfer option.

Terms & Conditions to Register for the Seminar/Conference/Event

Your registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-717-2436 or email us @ [email protected]

Payment:

Payment is required 2 days before the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. (our parent company).

Cancellations and substitutions for In-person Seminars:

Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund - less a $300 administration fee. No cancellations will be accepted - nor refunds issued - within 10 calendar days before the start date of the event.

On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($300) will be transferred to any future ComplianceOnline event and a credit note will be issued.

Substitutions may be made at any time. No-shows will be charged the full amount.

We discourage onsite registrations, however if you wish to register onsite, payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available, we will send the material after the conference is over.

In the event ComplianceOnline cancels the seminar, ComplianceOnline is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.

Cancellations and Substitutions for Virtual Seminars & Webinars:

Written cancellations through fax or email (from the person who has registered for the training) received at least 10 calendar days prior to the start date of the event will receive a refund — less a 30% administration fee. No cancellations will be accepted — nor refunds issued — within 10 calendar days from the start date of the event. On request by email or fax (before the training) a credit for the amount paid minus administration fees (30%) will be transferred to any future ComplianceOnline event and a credit note will be issued. Substitutions may be made at any time. No-shows will be charged the full amount. Some topics and speakers may be subject to change without notice.
Offers:
  • Early bird seats are limited and based on first-come, first-serve.
  • Multiple offers cannot be combined.
  • We need below information to serve you better

     

    +1-888-717-2436

    6201 America Center Drive Suite 240, San Jose, CA 95002, USA

    Follow Us

    facebook twitter linkedin youtube

     

    Copyright © 2023 ComplianceOnline.com MetricStream
    Our Policies: Terms of use | Privacy

    PAYMENT METHOD: 100% Secure Transaction

    payment method